As expected, PAK2 silencing significantly diminished the phosphorylation of Thr93 and Thr91 c-Jun in HCC cells, whereas it had no effects on total c-Jun and ALDOA expressions (Fig. 4C). The gene discussed is PAK2; the disease is hepatocellular carcinoma.